MENA Newswire, NEW YORK: Novo Nordisk’s blockbuster weight-loss drug Wegovy is now available in an oral pill form in the United States, marking a major…
Eli Lilly’s retatrutide achieved nearly 29% body weight loss and major knee pain reduction in a Phase 3 trial, reinforcing its strong obesity treatment profile.
